immunosuppressive therapy – Page 2 – Communicable Diseases Research

Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on Immunosuppression

Article

Published on 2022-11-012022-11-15
Journal: Transplantation and cellular therapy [Category] SARS, 진단, 치료기술,

Editorial: Chronic autoimmune arthritis, infections and vaccines

Editorial

Published on 2022-10-212023-07-10
Journal: Frontiers in Immunology [Category] COVID19(2023년),

[키워드] Arthritis Autoimmune disease COVID19 immunosuppressive therapy SARS-COV-2 infection Vaccines
[DOI] 10.3389/fimmu.2022.1058152 PMC 바로가기 [Article Type] Editorial

Acute encephalopathy in a 6-year-old child with concurrent COVID-19 infection: a case report from Saudi Arabia

Case report

Published on 2022-10-012022-10-05
Journal: International Journal of Infectious Diseases [Category] 치료기술, 치료제,

Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination

Article

Published on 2022-09-012022-11-15
Journal: RMD Open [Category] SARS, 진단,

[키워드] activated Activation antibody Autoimmune Autoimmune diseases Cellular immune response cellular response Combination correlated COVID-19 COVID-19 vaccination csDMARD cytokine cytokine profile drug drugs evaluated female first vaccination Frequency Heterologous highest humoral IgG immunosuppressive immunosuppressive therapy Inflammatory inhibitor investigated majority marker median age medications methotrexate monotherapy mRNA-based vaccine MTX Neutralising Antibodies neutralising antibody no difference not significant outcome Patient psoriatic arthritis quantification receiving rheumatic disease rheumatoid arthritis SARS-CoV-2 second vaccination Seroconversion spike-protein spondyloarthritis T-cell T-cell immunity T-lymphocyte T-lymphocyte subsets Therapies therapy titre treated vaccination
[DOI] 10.1136/rmdopen-2022-002293 PMC 바로가기

Evaluation of selected parameters of immune response to rubella virus, hepatitis B virus and varicella-zoster virus infections in children born to mothers after kidney or liver transplantation

Article

Published on 2022-09-012023-06-02
Journal: The journal of maternal-fetal & neonatal medicine [Category] B형 간염, 두창,

[키워드] antibody levels children of transplanted mothers immunosuppressive therapy Kidney transplantation Liver transplantation prenatal exposure.
[DOI] 10.1080/14767058.2020.1818219

Humoral and cellular response in convalescent COVID-19 lupus patients

회복기 COVID-19 루푸스 환자의 체액 및 세포 반응

Article

Published on 2022-08-122022-09-11
Journal: Scientific Reports [Category] SARS, 진단, 치료기술, 치료법, 치료제,

[키워드] accumulated adaptive Analysis analyzed antibodies antibody Antibody Response Antibody titer Antibody titers CD8 cellular response changes in collected confirmed cases confirmed COVID-19 case convalescent convalescent COVID-19 patient convalescent COVID-19 patients convalescent patient Convalescent patients COVID-19 COVID-19 disease COVID-19 incidence COVID-19 infection COVID-19 susceptibility declined decrease died dose dysregulation evaluated flow cytometry Gene expression analysis General population Health care higher risk Hospital admission humoral Humoral and cellular responses hypocomplementemia IgG antibodies immune dysregulation immune response immunological immunological profile Immunological studies Immunosuppression immunosuppressive immunosuppressive therapy impair incidence increase in Infection intensive care lack longitudinal longitudinal changes Lupus medical record memory cell Mild Patient patients PBMC PBMCs PCR-confirmed COVID-19 Prednisone predominant prospective cohort reduction required risk factor Risk factors SARS-CoV-2 IgG SARS-CoV-2 IgG antibodies SARS-CoV-2 IgG antibody severe COVID-19 disease severe disease severity Signaling SLE Surveillance susceptibility sustained Symptom symptom onset T cell Th17 Th2 response therapy were measured
[DOI] 10.1038/s41598-022-17334-5 PMC 바로가기 [Article Type] Article

Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort

진행중인 미코페놀레이트 치료는 만성 염증성 자가면역 질환 또는 간 이식 수혜자의 영향을 받는 환자에서 항-SARS-CoV-2 백신 반응을 손상시킵니다: RIVALSA 예상 코호트의 결과

Observational Study

Published on 2022-08-122022-09-11
Journal: Viruses [Category] SARS, 임상, 진단, 치료기술,

[키워드] 95% CI administration Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG anti-SARS-CoV-2 vaccination Antibody Response Antibody titers ARMS Arthritis Autoimmune Autoimmune disease Autoimmune diseases Autoimmune hepatitis calcineurin calcineurin inhibitors chronic cohort of patients Complete connective tissue disease Connective tissue diseases detectable develop Diagnosis dose dose reduction Effect effective Eligible patients enrolled evaluate evaluated example first dose healthy subjects hepatology identify IgG immunogenicity immunosuppressive immunosuppressive therapy Immunosuppressive treatment independent predictor independent predictors individual inhibitor liver liver transplant Liver transplantation MMF mRNA COVID-19 vaccine mRNA COVID-19 vaccines mRNA vaccine mRNA-based Multivariate analysis mycophenolate mycophenolate. neoplasia Novara observational study organ other diseases overlapped Patient patients performed predictor Prevent Prospective prospective observational study receiving recipients rejection required response Result rheumatoid arthritis rheumatological SARS-COV-2 infection selected Seroconversion seroconversion failure spondyloarthritis subgroups of patient suffered Suspension Tertiary therapy transplantation transplants treated Treatment unit Univariate analysis university vaccinated individual vaccination Vaccine vaccine response Vasculitis
[DOI] 10.3390/v14081766 PMC 바로가기 [Article Type] Observational Study

Persistent Fever and Positive PCR 90 Days Post-SARS-CoV-2 Infection in a Rituximab-Treated Patient: A Case of Late Antiviral Treatment

리툭시맙 치료 환자에서 SARS-CoV-2 감염 후 90일 동안 지속되는 발열 및 PCR 양성: 후기 항바이러스 치료 1례

Case Reports

Published on 2022-08-112022-09-11
Journal: Viruses [Category] SARS, 진단, 치료제,

[키워드] Antiviral treatment antivirals B cell B cell immune responses benefit Day defined diagnostic dominant Dyspnea early treatment feasible Fever full recovery high fever Hospitalized human long-term infection hyperinflammation Hypoxemia immune immune responses Immunocompromised Immunocompromised patients immunosuppressive immunosuppressive therapy infusion interval low-grade viral replication lower airway lower airways lung infiltrate lung infiltrates Mild mild to moderate moderate monoclonal monoclonal antibodies monoclonal antibody multiple sclerosis Patient patients PCR persistent persistent fever positive PCR test post infection Prophylactic receiving reduced reported Respiratory failure rituximab SARS-CoV-2 SARS-COV-2 infection sensitivity serum severe respiratory failure Symptom therapy Treatment treatment approach treatment approaches Viral viral replication
[DOI] 10.3390/v14081757 PMC 바로가기 [Article Type] Case Reports

Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases

급성 후 COVID-19는 염증성 장 질환에서 장 바이러스 항원 지속성을 특징으로 합니다

Article

Published on 2022-08-012022-09-11
Journal: Gastroenterology [Category] COVID19(2023년), SARS, 임상, 치료기술, 치료법,

[키워드] acute COVID-19 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 affected Antigen biochemical CD8 Chain Reaction clinical trials Confirmed COVID-19 infection controlled clinical trials coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection Culture detectable endoscopy enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluated expression of SARS-CoV-2 flow cytometry globe Gut gut mucosa IBD immune immune response immunofluorescence immunosuppressive immunosuppressive therapy Inflammation Inflammatory bowel disease intestine investigated large intestine majority means Mild nucleocapsid nucleocapsid protein pandemic Patient performed persistence polymerase chain polymerase chain reaction populations Postacute COVID-19 Quantitative quantitative polymerase chain reaction questionnaire reported RNA SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-CoV-2 RNA severe acute respiratory syndrome Coronavirus severity Stool syndrome T cells therapy tissue Viral antigen Viral Antigen Persistence. viral nucleocapsid protein viral transcripts virus cultivation
[DOI] 10.1053/j.gastro.2022.04.037 PMC 바로가기 [Article Type] Article

Balancing B cell responses to the allograft: implications for vaccination

동종이식에 대한 B 세포 반응 균형: 백신 접종에 대한 의미

Review

Published on 2022-07-272022-09-12
Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단,